Skip to main content
OpenTrials

Clinical trial condition

Chronic Plaque Psoriasis

Explore clinical trials studying Chronic Plaque Psoriasis. Study availability and eligibility vary by location and protocol.

46 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Chronic Plaque Psoriasis trial results

Completed

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis

NCT03010527

Conditions
Chronic Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Ps0011 708 Los Angeles, California, United States
  • Ps0011 706 Washington D.C., District of Columbia, United States
  • Ps0011 704 West Des Moines, Iowa, United States
  • Ps0011 738 Wilmington, North Carolina, United States
View all 36 locations
View Trial Details
Completed

Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque Psoriasis

NCT02905006

Conditions
Chronic Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Ps0010 711 Fremont, California, United States
  • Ps0010 708 Los Angeles, California, United States
  • Ps0010 706 Washington D.C., District of Columbia, United States
  • Ps0010 704 West Des Moines, Iowa, United States
View all 41 locations
View Trial Details
Completed

A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis

NCT02852967

Conditions
Chronic Plaque Psoriasis, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, +3 more
Locations
  • Alliance Dermatology and Mohs Center Phoenix, Arizona, United States
  • University of California, Irvine - Dermatology Clinical Research Center Irvine, California, United States
  • Dermatology Research Associates Los Angeles, California, United States
  • Renstar Medical Research Ocala, Florida, United States
View all 14 locations
View Trial Details
Completed

A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis

NCT00419666

Conditions
Chronic Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Dermatology Research of Arkansas Little Rock, Arkansas, United States
  • Children's Hospital, Department of Pediatric and Adolescent Dermatology San Diego, California, United States
  • Dermatology Center For Children & Young Adults Eagan, Minnesota, United States
  • University of Texas-Houston Medical Center Dept of Dermatology Houston, Texas, United States
View Trial Details
Completed

Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis

NCT02690701

Conditions
Chronic Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Santa Ana, California, United States
  • Novartis Investigative Site Rockville, Maryland, United States
  • Novartis Investigative Site St Louis, Missouri, United States
View Trial Details
Completed

Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis

NCT01358578

Conditions
Chronic Plaque Psoriasis, Dermatitis, Psoriasis, +3 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site San Diego, California, United States
  • Novartis Investigative Site San Diego, California, United States
View all 152 locations
View Trial Details
Completed

Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis

NCT02969018

Conditions
Chronic Plaque Psoriasis
Locations
  • Northwest Arkansas Clinical Trials Center, PLLC/Hull Dermatology, PA Rogers, Arkansas, United States
  • Anaheim Clinical Trials, LLC Anaheim, California, United States
  • California Dermatology & Clinical Research Institute Encinitas, California, United States
  • Emil A. Tanghetti, MD dba Center for Dermatology and Laser Surgery Sacramento, California, United States
View all 44 locations
View Trial Details

Related conditions